The promise and challenges of targeting RSK for the treatment of cancer.
Article Details
- CitationCopy to clipboard
Stratford AL, Dunn SE
The promise and challenges of targeting RSK for the treatment of cancer.
Expert Opin Ther Targets. 2011 Jan;15(1):1-4. doi: 10.1517/14728222.2011.537656.
- PubMed ID
- 21142801 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Acetylsalicylic acid Ribosomal protein S6 kinase alpha-3 Protein Humans UnknownInhibitorDetails